The landscape of the American pharmaceutical industry underwent a significant structural shift on September 29, 2026, as the federal government…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape of American pharmaceutical manufacturing is undergoing a seismic shift as the U.S. government implements a aggressive trade policy…
Read MorePharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape for pharmaceutical manufacturing in the United States underwent a seismic shift on September 29, as federal tariffs on…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape for pharmaceutical manufacturing in the United States underwent a significant shift on September 29, 2026, as the scope…
Read More
Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…
Read More
HNSCC market is expected to reach to $4.5bn across 8MM by 2034 – Pharmaceutical Technology
The global market for head and neck squamous cell carcinoma (HNSCC) therapeutics is poised for significant expansion, with projections indicating…
Read More
